STOCK TITAN

BiomX to Host Second Quarter 2021 Financial Results Conference Call and Webcast on August 16, 2021

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings
Rhea-AI Summary

BiomX Inc. (PHGE) announced a conference call and webcast on August 16, 2021, at 8:00 a.m. EDT to discuss its second-quarter financial results and provide business updates. The company specializes in developing natural and engineered phage therapies targeting pathogenic bacteria affecting skin and chronic diseases, including inflammatory bowel disease and colorectal cancer. Investors can access the live and archived webcast via BiomX's website.

Positive
  • None.
Negative
  • None.

NESS ZIONA, Israel, Aug. 12, 2021 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE American: PHGE) (“BiomX” or the “Company”), a clinical-stage microbiome company advancing novel natural and engineered phage therapies that target specific pathogenic bacteria, today announced that the Company will host a conference call and a live audio webcast on Monday, August 16, 2021, at 8:00 a.m. EDT, to report second quarter 2021 financial results and provide business updates. To participate in the conference call, please dial 1-877-407-0724 (U.S.), 1-809-406-247 (Israel) or 1-201-389-0898 (International). The live and archived webcast will be available in the Investors section of the Company’s website at www.biomx.com.

About BiomX

BiomX is a clinical-stage microbiome company developing both natural and engineered phage cocktails designed to target and destroy bacteria that affect the appearance of skin, as well as target bacteria in the treatment of chronic diseases, such as inflammatory bowel disease, primary sclerosing cholangitis, cystic fibrosis, atopic dermatitis and colorectal cancer. BiomX discovers and validates proprietary bacterial targets and customizes phage compositions against these targets.

Additional information is available at www.biomx.com, the content of which does not form a part of this press release.

BiomX, Inc.
Assaf Oron
Chief Business Officer
+972 (54) 222-8901
assafo@biomx.com  

Media:
LifeSci Advisors, LLC
John Mullaly
617-429-3548

Source: BiomX Inc


FAQ

What are the main topics BiomX will discuss in the August 16, 2021 conference call?

BiomX will discuss its second-quarter 2021 financial results and provide business updates during the conference call on August 16, 2021.

How can I access the live webcast for BiomX's conference call?

You can access the live and archived webcast on BiomX's website in the Investors section.

What is the focus of BiomX's research and development?

BiomX focuses on developing natural and engineered phage therapies targeting pathogenic bacteria related to skin conditions and chronic diseases.

BiomX Inc.

NYSE:PHGE

PHGE Rankings

PHGE Latest News

PHGE Stock Data

9.35M
13.62M
11.68%
52.31%
0.13%
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
United States of America
NESS ZIONA